These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense. Sharma PK, Varshney R. Free Radic Res; 2012 Dec; 46(12):1446-57. PubMed ID: 22946929 [Abstract] [Full Text] [Related]
3. Contribution of oxidative stress to radiosensitization by a combination of 2-DG and 6-AN in human cancer cell line. Varshney R, Adhikari JS, Dwarakanath BS. Indian J Exp Biol; 2003 Dec; 41(12):1384-91. PubMed ID: 15320490 [Abstract] [Full Text] [Related]
6. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy. Kalia VK, Prabhakara S, Narayanan V. J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297 [Abstract] [Full Text] [Related]
7. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors. Kalia VK. Indian J Exp Biol; 1993 Apr; 31(4):312-5. PubMed ID: 8359829 [Abstract] [Full Text] [Related]
14. Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose. Kalia VK. Indian J Med Res; 1999 May 15; 109():182-7. PubMed ID: 10643143 [Abstract] [Full Text] [Related]
18. Inhibition of pentose cycle of A549 cells by 6-aminonicotinamide: consequences for aerobic and hypoxic radiation response and for radiosensitizer action. Varnes ME. NCI Monogr; 1988 May 15; (6):199-203. PubMed ID: 2965307 [Abstract] [Full Text] [Related]
19. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure. Khaitan D, Chandna S, Dwarakanath SB. J Cancer Res Ther; 2009 Sep 15; 5 Suppl 1():S67-73. PubMed ID: 20009299 [Abstract] [Full Text] [Related]